| Literature DB >> 28811274 |
Sven W Görgens1, Tim Benninghoff2, Kristin Eckardt1,3, Christian Springer2, Alexandra Chadt2, Anita Melior1, Jakob Wefers1, Andrea Cramer1, Jørgen Jensen4, Kåre I Birkeland5, Christian A Drevon3, Hadi Al-Hasani2,6, Jürgen Eckel7,6.
Abstract
Skeletal muscle insulin resistance is the hallmark of type 2 diabetes and develops long before the onset of the disease. It is well accepted that physical activity improves glycemic control, but the knowledge on underlying mechanisms mediating the beneficial effects remains incomplete. Exercise is accompanied by a decrease in intramuscular oxygen levels, resulting in induction of HIF-1α. HIF-1α is a master regulator of gene expression and might play an important role in skeletal muscle function and metabolism. Here we show that HIF-1α is important for glucose metabolism and insulin action in skeletal muscle. By using a genome-wide gene expression profiling approach, we identified RAB20 and TXNIP as two novel exercise/HIF-1α-regulated genes in skeletal muscle. Loss of Rab20 impairs insulin-stimulated glucose uptake in human and mouse skeletal muscle by blocking the translocation of GLUT4 to the cell surface. In addition, exercise/HIF-1α downregulates the expression of TXNIP, a well-known negative regulator of insulin action. In conclusion, we are the first to demonstrate that HIF-1α is a key regulator of glucose metabolism in skeletal muscle by directly controlling the transcription of RAB20 and TXNIP These results hint toward a novel function of HIF-1α as a potential pharmacological target to improve skeletal muscle insulin sensitivity.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28811274 DOI: 10.2337/db16-1488
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461